Now showing items 1-3 of 3
Ischemia-modified albumin and cardiovascular risk markers in polycystic ovary syndrome with or without insulin resistance
(Elsevier Science Inc, 2011)
The aim of this study was to evaluate ischemia-modified albumin levels (IMA) in polycystic ovary syndrome (PCOS) cases with and without insulin resistance and the correlation of IMA with carotid intima media thickness, ...
The association between ischemia modified albumin and placental histopathology in uncomplicated term deliveries
Ischemia modified albumin (IMA) is a marker of ischemia elevated in different clinical conditions and its use for hypoxia in perinatology is of current interest. We aimed to investigate the association between maternal ...
The impact of route of anesthesia on maternal and fetal ischemia modified albumin levels at cesarean section: a prospective randomized study
Objective: Ischemia modified albumin has been shown to increase in ischemic situations, and has also been shown to increase in fetal cord blood in deliveries by cesarean section. The aim of this study is to reveal whether ...